Logo image of RUN

SUNRUN INC (RUN) Stock Fundamental Analysis

NASDAQ:RUN - Nasdaq - US86771W1053 - Common Stock - Currency: USD

6.57  -0.28 (-4.09%)

After market: 6.65 +0.08 (+1.22%)

Fundamental Rating

2

Taking everything into account, RUN scores 2 out of 10 in our fundamental rating. RUN was compared to 97 industry peers in the Electrical Equipment industry. RUN may be in some trouble as it scores bad on both profitability and health. RUN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RUN was profitable.
In the past year RUN has reported a negative cash flow from operations.
In the past 5 years RUN reported 4 times negative net income.
In the past 5 years RUN always reported negative operating cash flow.
RUN Yearly Net Income VS EBIT VS OCF VS FCFRUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

The Return On Assets of RUN (-14.30%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -111.43%, RUN is doing worse than 65.98% of the companies in the same industry.
Industry RankSector Rank
ROA -14.3%
ROE -111.43%
ROIC N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
RUN Yearly ROA, ROE, ROICRUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

RUN has a Gross Margin (16.12%) which is in line with its industry peers.
RUN's Gross Margin has declined in the last couple of years.
RUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
RUN Yearly Profit, Operating, Gross MarginsRUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

RUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RUN has been increased compared to 1 year ago.
RUN has more shares outstanding than it did 5 years ago.
RUN has a worse debt/assets ratio than last year.
RUN Yearly Shares OutstandingRUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
RUN Yearly Total Debt VS Total AssetsRUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

RUN has an Altman-Z score of -0.22. This is a bad value and indicates that RUN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of RUN (-0.22) is comparable to the rest of the industry.
A Debt/Equity ratio of 4.99 is on the high side and indicates that RUN has dependencies on debt financing.
RUN has a worse Debt to Equity ratio (4.99) than 78.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.99
Debt/FCF N/A
Altman-Z -0.22
ROIC/WACCN/A
WACC4.5%
RUN Yearly LT Debt VS Equity VS FCFRUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

RUN has a Current Ratio of 1.29. This is a normal value and indicates that RUN is financially healthy and should not expect problems in meeting its short term obligations.
RUN has a Current ratio of 1.29. This is in the lower half of the industry: RUN underperforms 65.98% of its industry peers.
RUN has a Quick Ratio of 1.29. This is a bad value and indicates that RUN is not financially healthy enough and could expect problems in meeting its short term obligations.
RUN has a Quick ratio (0.99) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.99
RUN Yearly Current Assets VS Current LiabilitesRUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

RUN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.10%, which is quite impressive.
The Earnings Per Share has been growing by 42.86% on average over the past years. This is a very strong growth
The Revenue has decreased by -9.83% in the past year.
The Revenue has been growing by 18.87% on average over the past years. This is quite good.
EPS 1Y (TTM)116.1%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%188.13%
Revenue 1Y (TTM)-9.83%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%0.37%

3.2 Future

Based on estimates for the next years, RUN will show a small growth in Earnings Per Share. The EPS will grow by 5.36% on average per year.
Based on estimates for the next years, RUN will show a quite strong growth in Revenue. The Revenue will grow by 11.47% on average per year.
EPS Next Y-214.06%
EPS Next 2Y-71.7%
EPS Next 3Y-43.84%
EPS Next 5Y5.36%
Revenue Next Year7.15%
Revenue Next 2Y10.12%
Revenue Next 3Y10.93%
Revenue Next 5Y11.47%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RUN Yearly Revenue VS EstimatesRUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
RUN Yearly EPS VS EstimatesRUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4 -6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.52, the valuation of RUN can be described as very cheap.
Based on the Price/Earnings ratio, RUN is valued cheaply inside the industry as 95.88% of the companies are valued more expensively.
RUN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.63.
RUN is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 5.52
Fwd PE N/A
RUN Price Earnings VS Forward Price EarningsRUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

62.89% of the companies in the same industry are more expensive than RUN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 292
RUN Per share dataRUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

A cheap valuation may be justified as RUN's earnings are expected to decrease with -43.84% in the coming years.
PEG (NY)N/A
PEG (5Y)0.13
EPS Next 2Y-71.7%
EPS Next 3Y-43.84%

More info and screens

0

5. Dividend

5.1 Amount

RUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNRUN INC

NASDAQ:RUN (4/21/2025, 8:00:01 PM)

After market: 6.65 +0.08 (+1.22%)

6.57

-0.28 (-4.09%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners112.59%
Inst Owner Change-0.45%
Ins Owners2.24%
Ins Owner Change3.57%
Market Cap1.49B
Analysts72.67
Price Target14.08 (114.31%)
Short Float %22.02%
Short Ratio4.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)244.53%
Min EPS beat(2)-157.51%
Max EPS beat(2)646.57%
EPS beat(4)3
Avg EPS beat(4)192.23%
Min EPS beat(4)-157.51%
Max EPS beat(4)646.57%
EPS beat(8)4
Avg EPS beat(8)-307.64%
EPS beat(12)7
Avg EPS beat(12)-99.53%
EPS beat(16)9
Avg EPS beat(16)-66.08%
Revenue beat(2)0
Avg Revenue beat(2)-5.15%
Min Revenue beat(2)-5.73%
Max Revenue beat(2)-4.56%
Revenue beat(4)1
Avg Revenue beat(4)-3.2%
Min Revenue beat(4)-5.73%
Max Revenue beat(4)0.68%
Revenue beat(8)2
Avg Revenue beat(8)-1.88%
Revenue beat(12)6
Avg Revenue beat(12)3.05%
Revenue beat(16)10
Avg Revenue beat(16)3.58%
PT rev (1m)-7.14%
PT rev (3m)-24.52%
EPS NQ rev (1m)2.03%
EPS NQ rev (3m)-1.5%
EPS NY rev (1m)-75.64%
EPS NY rev (3m)-78.47%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)-9.08%
Revenue NY rev (1m)-2.2%
Revenue NY rev (3m)-6.85%
Valuation
Industry RankSector Rank
PE 5.52
Fwd PE N/A
P/S 0.73
P/FCF N/A
P/OCF N/A
P/B 0.58
P/tB 0.58
EV/EBITDA 292
EPS(TTM)1.19
EY18.11%
EPS(NY)-1.36
Fwd EYN/A
FCF(TTM)-15.33
FCFYN/A
OCF(TTM)-3.39
OCFYN/A
SpS9.01
BVpS11.29
TBVpS11.29
PEG (NY)N/A
PEG (5Y)0.13
Profitability
Industry RankSector Rank
ROA -14.3%
ROE -111.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.12%
FCFM N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
F-Score3
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 4.99
Debt/FCF N/A
Debt/EBITDA 266.24
Cap/Depr 435.03%
Cap/Sales 132.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.99
Altman-Z -0.22
F-Score3
WACC4.5%
ROIC/WACCN/A
Cap/Depr(3y)457.15%
Cap/Depr(5y)441.02%
Cap/Sales(3y)111.53%
Cap/Sales(5y)108.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.1%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%188.13%
EPS Next Y-214.06%
EPS Next 2Y-71.7%
EPS Next 3Y-43.84%
EPS Next 5Y5.36%
Revenue 1Y (TTM)-9.83%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%0.37%
Revenue Next Year7.15%
Revenue Next 2Y10.12%
Revenue Next 3Y10.93%
Revenue Next 5Y11.47%
EBIT growth 1Y30.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year144.91%
EBIT Next 3Y42.39%
EBIT Next 5Y26.41%
FCF growth 1Y-1.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.65%
OCF growth 3YN/A
OCF growth 5YN/A